Tag: biosimilar coding
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Candidemia & Disseminated Candida Infections: Why Patient Education Matters
Oct, 21 2025
False Advertising in Generics: Legal Risks and Rules You Can't Ignore
Nov, 24 2025
Black Box Warnings: What You Need to Know About the FDA’s Strongest Drug Safety Alerts
Nov, 19 2025
Buying Generic Ativan Online: Legal Risks, Safety Warnings, and Legitimate Ways to Save Money
May, 6 2026
Vasculitis: Understanding Autoimmune Inflammation of Blood Vessels
Jan, 18 2026